Smiths Detection and Novartis Diagnosics sign deal for LATE PCR technology

Smiths Detection and Novartis Diagnostics have entered an collaboration and license agreement for marketing the Bio-Seeq instrument. This uses LATE PCR technology developed in the Wangh lab at Brandeis and licensed by Smiths Detection.

Protected by Akismet
Blog with WordPress

Welcome Guest | Login (Brandeis Members Only)